Tempest Therapeutics (TPST) Acquisitions (2018)
Tempest Therapeutics (TPST) posted Acquisitions of $524000.0 for Q1 2018.
Tempest Therapeutics (TPST) Acquisitions (2018) Analysis & Trends
Tempest Therapeutics has reported Acquisitions for 1 years, with the latest figure at $524000.0 in Q1 2018.
- Quarterly Acquisitions changed N/A year-over-year to $524000.0 in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $524000.0 (changed N/A YoY) and the FY2018 annual result came in at $524000.0, up 213.42% from the prior year.
- Acquisitions steadied at $524000.0 in Q1 2018 per TPST's latest filing.
- Over five years, Acquisitions peaked at $524000.0 in Q1 2018 and troughed at $524000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 524,000.00 |